Publication | Open Access

ROS/KRAS/AMPK Signaling Contributes to Gemcitabine-Induced Stem-like Cell Properties in Pancreatic Cancer

Cancer ResearchSignaling PathwayPancreatic CancerCell RegulationMedicineStem CellsStem Cell ResearchTumor SuppressorRadiation OncologyCancer BiologyCell BiologyCell SignalingTumor MicroenvironmentTumor BiologyHealth Sciences